Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
Chia Siang Kow, Syed Shahzad Hasan
Topics & Concepts
MedicineRheumatologyRituximabCoronavirus disease 2019 (COVID-19)Internal medicineDisease2019-20 coronavirus outbreakAdverse effectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineInfectious disease (medical specialty)VirologyLymphomaOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19